These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31493385)

  • 1. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
    Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
    Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo.
    Yu F; Lin Y; Xu X; Liu W; Tang D; Zhou X; Wang G; Zheng Y; Xie A
    Int J Oncol; 2020 Jul; 57(1):139-150. PubMed ID: 32319597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
    Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of
    Yu W; Liu W; Feng Y; Zhu C
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):26-36. PubMed ID: 35089075
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects and mechanisms of GSG2 in esophageal cancer progression.
    Geng C; Wang Q; Xing PF; Wang M; Tong SD; Zhou JY
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3409-3421. PubMed ID: 35939116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
    Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
    Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
    Tang Y; Dai G; Yang Y; Liu H
    J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
    Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
    Chen Y; Fu D; Zhao H; Cheng W; Xu F
    Aging (Albany NY); 2020 May; 12(10):8858-8879. PubMed ID: 32439830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HASPIN is involved in the progression of gallbladder carcinoma.
    Zhu D; Gu X; Lin Z; Yu D; Wang J; Li L
    Exp Cell Res; 2020 May; 390(2):111863. PubMed ID: 31987787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ cell-specific gene 2 accelerates cell cycle in epithelial ovarian cancer by inhibiting GSK3α-p27 cascade.
    Zhu K; Ma X; Guan X; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R
    J Mol Histol; 2024 Jun; 55(3):241-251. PubMed ID: 38613588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
    Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
    Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
    Li L; Li S; Wang H; Li L; Wang P; Shen D; Dang X
    Biochem Biophys Res Commun; 2022 Oct; 625():109-115. PubMed ID: 35952607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.